Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Welltower | Shankh S. Mitra | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 2,485,146 | 2,485,146 | - | - | LTIP Units | |
| Welltower | Shankh S. Mitra | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 2,485,146 | 2,485,146 | - | - | Other Stock Units | |
| Gabelli Healthcare & WellnessRx Trust | Mario J. Gabelli | Director, Ten Percent Owner, Control Person of Adviser | Purchase of securities on an exchange or from another person at price $ 10.18 per share. | 30 Oct 2025 | 1,800,000 | 2,000,000 | - | 10.2 | 18,322,380 | Series G Cumulative Preferred Shares |
| UWM Holdings Corp (Class A) | Mathew Ishbia | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.56 per share. | 30 Oct 2025 | 596,356 | 1,221,680 | - | 5.6 | 3,315,739 | Class A Common Stock |
| UWM Holdings Corp (Class A) | Mathew Ishbia | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.76 per share. | 30 Oct 2025 | 596,356 | 28,968 | - | 5.8 | 3,435,011 | Class A Common Stock |
| UWM Holdings Corp (Class A) | Mathew Ishbia | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.59 per share. | 30 Oct 2025 | 596,356 | 625,324 | - | 5.6 | 3,333,630 | Class A Common Stock |
| Alpha Modus Holdings Inc (Class A) | William Alessi | Director, Chief Executive Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Oct 2025 | 430,000 | 3,870,000 | - | - | Series C Preferred Stock | |
| Cyclacel Pharma Inc | Yee Lung Ong | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.80 per share. | 30 Oct 2025 | 248,814 | 0 (0%) | 1% | 1.8 | 447,865 | Common Stock |
| Ventas | Debra A. Cafaro | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 224,360 | 134,192 | - | - | Stock Option (Right to Buy) | |
| Ventas | Debra A. Cafaro | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 74.34 per share. | 30 Oct 2025 | 224,360 | 1,145,695 (0%) | 0% | 74.3 | 16,678,384 | Common Stock |
| Ventas | Debra A. Cafaro | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.22 per share. | 30 Oct 2025 | 224,360 | 1,370,055 (0%) | 0% | 62.2 | 13,959,679 | Common Stock |
| Alpha Modus Holdings Inc (Class A) | Christopher Phillip Chumas | Chief Sales Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Oct 2025 | 215,000 | 215,000 | - | - | Series C Preferred Stock | |
| Alpha Modus Holdings Inc (Class A) | Christopher Phillip Chumas | Chief Sales Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Oct 2025 | 215,000 | 430,000 | - | - | Series C Preferred Stock | |
| Anixa Biosciences Inc | Amit Kumar | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 200,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Anixa Biosciences Inc | Amit Kumar | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.92 per share. | 30 Oct 2025 | 200,000 | 779,925 (3%) | 0% | 2.9 | 584,000 | Common Stock |
| Calix Inc | Michael Weening | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.84 per share. | 30 Oct 2025 | 200,000 | 216,117 (0%) | 0% | 7.8 | 1,568,000 | Common Stock |
| Calix Inc | Michael Weening | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 200,000 | 74,000 | - | - | Stock Option (right to buy) | |
| Anixa Biosciences Inc | Amit Kumar | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.06 per share. | 30 Oct 2025 | 169,439 | 610,486 (2%) | 0% | 4.1 | 687,922 | Common Stock |
| Churchill Downs Inc | William C. Carstanjen | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 151,942 | 1,743,586 (4%) | 0% | 0 | Common Stock | |
| Churchill Downs Inc | William C. Carstanjen | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 151,942 | 146,367 | - | - | Restricted Stock Units | |
| Calix Inc | Michael Weening | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 64.63 per share. | 30 Oct 2025 | 150,000 | 66,117 (0%) | 0% | 64.6 | 9,694,200 | Common Stock |
| Moelis & Co (Class A) | Kenneth Moelis | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 133,092 | 4,191,326 | - | - | Class B Common Stock, par value $0.01 | |
| Monolithic Power | Michael R. Hsing | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1096.63 per share. | 30 Oct 2025 | 121,918 | 995,669 (2%) | 0% | 1096.6 | 133,698,936 | Common Stock |
| Hain Celestial Grp Inc | Celeste A. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 114,729 | 202,721 (0%) | 0% | 0 | Common Stock | |
| Hain Celestial Grp Inc | Dawn M. Zier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 114,729 | 402,958 (0%) | 0% | 0 | Common Stock | |
| Hain Celestial Grp Inc | Michael B. Sims | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 114,729 | 415,484 (0%) | 0% | 0 | Common Stock | |
| Hain Celestial Grp Inc | Shervin J. Korangy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 114,729 | 209,355 (0%) | 0% | 0 | Common Stock | |
| Hain Celestial Grp Inc | Carlyn R. Taylor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 114,729 | 318,160 (0%) | 0% | 0 | Common Stock | |
| Hain Celestial Grp Inc | Neil Campbell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 114,729 | 240,298 (0%) | 0% | 0 | Common Stock | |
| Cyclacel Pharma Inc | Kim Choy Yap | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.81 per share. | 30 Oct 2025 | 112,260 | 28,500 (0%) | 0% | 1.8 | 202,854 | Common Stock |
| Mirion Tech Inc (Class A) | Thomas Logan | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Oct 2025 | 106,188 | 3,349,551 | - | 0 | Class A Common Stock | |
| Avantor Inc | Gregory L. Summe | Director | Purchase of securities on an exchange or from another person at price $ 11.25 per share. | 30 Oct 2025 | 100,000 | 300,000 (0%) | 0% | 11.3 | 1,125,000 | Common Stock |
| Solstice Advanced Materials | David B. Sewell | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 98,620 | 98,620 | - | - | Restricted Stock Units | |
| MSC Industrial Direct Co. Inc (Class A) | Mitchell Jacobson | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 84.92 per share. | 30 Oct 2025 | 95,779 | 2,219,295 (4%) | 0% | 84.9 | 8,133,974 | Class A Common Stock |
| Churchill Downs Inc | William E. Mudd | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 94,966 | 28,359 | - | - | Restricted Stock Units | |
| Churchill Downs Inc | William E. Mudd | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 94,966 | 776,273 (1%) | 0% | 0 | Common Stock | |
| Champions Oncology Inc | Joel Ackerman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. | 30 Oct 2025 | 94,405 | 1,056,539 (9%) | 0% | 2.1 | 198,251 | Common Stock |
| Champions Oncology Inc | Joel Ackerman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 94,405 | 0 | - | - | Option to purchase Common Stock | |
| Gaia Inc (Class A) | Yonathan Abraham Nuta | COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 85,000 | 85,000 | - | - | Restricted Share Units | |
| Calix Inc | Michael Weening | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.84 per share. | 30 Oct 2025 | 74,000 | 90,117 (0%) | 0% | 7.8 | 580,160 | Common Stock |
| Calix Inc | Michael Weening | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 74,000 | 0 | - | - | Stock Option (right to buy) | |
| Calix Inc | Michael Weening | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 67.42 per share. | 30 Oct 2025 | 74,000 | 16,117 (0%) | 0% | 67.4 | 4,989,102 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 1.28 per share. | 30 Oct 2025 | 73,192 | 4,003,728 | - | 1.3 | 93,686 | Common Stock |
| AMC Networks Inc (Class A) | Patrick F. Dolan | Ten Percent Owner, Member of 13(d) Group | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 71,478 | 77,673 (0%) | 0% | 0 | Class A Common Stock | |
| AMC Networks Inc (Class A) | Patrick F. Dolan | Ten Percent Owner, Member of 13(d) Group | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 71,478 | 0 | - | - | Restricted Stock Units | |
| Churchill Downs Inc | William C. Carstanjen | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.40 per share. | 30 Oct 2025 | 68,071 | 1,675,515 (4%) | 0% | 100.4 | 6,834,328 | Common Stock |
| Qualys Inc | Sumedh S. Thakar | Director, CEO & PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 61,092 | 265,043 (0%) | 0% | 0 | Common Stock | |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 1.29 per share. | 30 Oct 2025 | 60,369 | 3,943,359 | - | 1.3 | 77,876 | Common Stock |
| Werewolf Therapeutics Inc | Luke B. Evnin | Director | Sale of securities on an exchange or to another person at price $ 1.43 per share. | 30 Oct 2025 | 55,795 | 4,076,920 | - | 1.4 | 79,787 | Common Stock |
| Amrize Ltd - Registered Shares | Jan Philipp Jenisch | Director, Chairman & CEO | Purchase of securities on an exchange or from another person at price $ 52.64 per share. | 30 Oct 2025 | 55,000 | 1,505,000 | - | 52.6 | 2,895,200 | Ordinary Shares |
| Amrize Ltd - Registered Shares | Jan Philipp Jenisch | Director, Chairman & CEO | Purchase of securities on an exchange or from another person at price $ 52.88 per share. | 30 Oct 2025 | 55,000 | 505,000 | - | 52.9 | 2,908,400 | Ordinary Shares |
| Monolithic Power | Deming Xiao | EVP, Global Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1096.63 per share. | 30 Oct 2025 | 54,543 | 201,637 (0%) | 0% | 1096.6 | 59,813,490 | Common Stock |
| Monolithic Power | Maurice Sciammas | EVP, WW Sales & Marketing | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1096.63 per share. | 30 Oct 2025 | 54,543 | 183,306 (0%) | 0% | 1096.6 | 59,813,490 | Common Stock |
| Monolithic Power | Saria Tseng | EVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1096.63 per share. | 30 Oct 2025 | 54,543 | 207,331 (0%) | 0% | 1096.6 | 59,813,490 | Common Stock |
| Micron Tech | Mark J. Murphy | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 225.87 per share. | 30 Oct 2025 | 51,149 | 242,040 (0%) | 0% | 225.9 | 11,553,025 | Common Stock |
| QuantumScape Corp (Class A) | Michael O. McCarthy | CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 15.78 per share. | 30 Oct 2025 | 50,000 | 1,376,118 | - | 15.8 | 788,985 | Class A Common Stock |
| QuantumScape Corp (Class A) | Michael O. McCarthy | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.38 per share. | 30 Oct 2025 | 50,000 | 1,426,118 | - | 2.4 | 118,850 | Class A Common Stock |
| QuantumScape Corp (Class A) | Michael O. McCarthy | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 50,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Calix Inc | Michael Weening | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 67.55 per share. | 30 Oct 2025 | 50,000 | 16,117 (0%) | 0% | 67.5 | 3,377,280 | Common Stock |
| Monolithic Power | T. Bernie Blegen | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1096.63 per share. | 30 Oct 2025 | 48,298 | 77,332 (0%) | 0% | 1096.6 | 52,965,036 | Common Stock |
| UiPath Inc (Class A) | Daniel Dines | Director, CEO and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 15.73 per share. | 30 Oct 2025 | 45,000 | 29,468,585 | - | 15.7 | 707,643 | Class A Common Stock |
| Churchill Downs Inc | William E. Mudd | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.40 per share. | 30 Oct 2025 | 43,258 | 733,015 (1%) | 0% | 100.4 | 4,343,103 | Common Stock |
| Ventas | Debra A. Cafaro | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 41,288 | 358,552 | - | - | Stock Option (Right to Buy) | |
| Ventas | Debra A. Cafaro | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 73.64 per share. | 30 Oct 2025 | 41,288 | 1,145,695 (0%) | 0% | 73.6 | 3,040,345 | Common Stock |
| Ventas | Debra A. Cafaro | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.24 per share. | 30 Oct 2025 | 41,288 | 1,186,983 (0%) | 0% | 63.2 | 2,611,053 | Common Stock |
| Universal Insurance Holdings Inc | Jon W. Springer | Director | Sale of securities on an exchange or to another person at price $ 31.41 per share. | 30 Oct 2025 | 35,435 | 271,628 (0%) | 0% | 31.4 | 1,113,081 | Common Stock |
| Petmed Express Inc | James LaCamp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 34,866 | 34,866 (0%) | 0% | 0 | Common Stock | |
| Qualys Inc | Joo Mi Kim | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 34,212 | 127,076 (0%) | 0% | 0 | Common Stock | |
| MSC Industrial Direct Co. Inc (Class A) | Mitchell Jacobson | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 84.76 per share. | 30 Oct 2025 | 34,073 | 2,253,368 (4%) | 0% | 84.8 | 2,888,167 | Class A Common Stock |
| Petmed Express Inc | Justin L. Mennen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 33,846 | 42,719 (0%) | 0% | 0 | Common Stock | |
| Petmed Express Inc | Leah A. Solivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 33,846 | 42,289 (0%) | 0% | 0 | Common Stock | |
| Petmed Express Inc | Peter Batushansky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 33,846 | 36,373 (0%) | 0% | 0 | Common Stock | |
| Petmed Express Inc | Gian M. Fulgoni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 33,846 | 158,356 (0%) | 0% | 0 | Common Stock | |
| Micron Tech | Mark J. Murphy | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 224.92 per share. | 30 Oct 2025 | 32,202 | 293,189 (0%) | 0% | 224.9 | 7,242,874 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 31.44 per share. | 30 Oct 2025 | 31,379 | 738,809 (1%) | 0% | 31.4 | 986,691 | Common Stock |
| Old Second Bancorp Inc | Darin Campbell | Director, President, Powersports Lending | Sale of securities on an exchange or to another person at price $ 17.89 per share. | 30 Oct 2025 | 31,159 | 0 (0%) | 0% | 17.9 | 557,313 | Old second Bancorp Inc., Common Stock |
| Ventas | Debra A. Cafaro | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 30,966 | 399,840 | - | - | Stock Option (Right to Buy) | |
| Ventas | Debra A. Cafaro | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 74.32 per share. | 30 Oct 2025 | 30,966 | 1,145,695 (0%) | 0% | 74.3 | 2,301,319 | Common Stock |
| Ventas | Debra A. Cafaro | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.71 per share. | 30 Oct 2025 | 30,966 | 1,176,661 (0%) | 0% | 73.7 | 2,282,504 | Common Stock |
| Watts Water Tech Inc (Class A) | Timothy P. Horne | Ten Percent Owner | 30 Oct 2025 | 30,000 | 920,000 | - | - | Class B Common Stock | ||
| Watts Water Tech Inc (Class A) | Timothy P. Horne | Ten Percent Owner | 30 Oct 2025 | 30,000 | 30,000 (0%) | 0% | 0 | Class A Common Stock | ||
| Flotek Ind Inc | Ryan Gillis Ezell | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 30,000 | 0 | - | - | Performance Based Restricted Stock Unit | |
| Flotek Ind Inc | Ryan Gillis Ezell | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 30,000 | 179,511 (0%) | 0% | - | Common Shares | |
| MSC Industrial Direct Co. Inc (Class A) | Mitchell Jacobson | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 84.79 per share. | 30 Oct 2025 | 30,000 | 2,305,322 (5%) | 0% | 84.8 | 2,543,700 | Class A Common Stock |
| Solstice Advanced Materials | Tina Pierce | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 29,586 | 29,586 | - | - | Restricted Stock Units | |
| Pacific Gas & Electric | Jason M. Glickman | EVP, EPS at PG&E Company | Sale of securities on an exchange or to another person at price $ 15.95 per share. | 30 Oct 2025 | 29,473 | 89,179 (0%) | 0% | 15.9 | 470,094 | Common Stock |
| Solstice Advanced Materials | Jason Michael Clifford | SVP and Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 28,974 | 28,974 | - | - | Restricted Stock Units | |
| Solstice Advanced Materials | David B. Sewell | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 28,514 | 28,514 | - | - | Restricted Stock Units | |
| Old Second Bancorp Inc | Darin Campbell | Director, President, Powersports Lending | Sale of securities on an exchange or to another person at price $ 18.27 per share. | 30 Oct 2025 | 26,406 | 31,159 (0%) | 0% | 18.3 | 482,329 | Old second Bancorp Inc., Common Stock |
| Solstice Advanced Materials | Tina Pierce | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 25,134 | 25,134 | - | - | Stock Option (Right to buy) | |
| Solstice Advanced Materials | Tina Pierce | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 25,050 | 25,050 | - | - | Stock Option (Right to buy) | |
| Snowflake Inc (Class A) | Benoit Dageville | Director, Founder and Chief Architect | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.48 per share. | 30 Oct 2025 | 25,000 | 75,519 | - | 13.5 | 337,000 | Common Stock |
| Snowflake Inc (Class A) | Benoit Dageville | Director, Founder and Chief Architect | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 25,000 | 217,927 | - | - | Stock Option (Right to Buy) | |
| Snowflake Inc (Class A) | Benoit Dageville | Director, Founder and Chief Architect | Sale of securities on an exchange or to another person at price $ 265.00 per share. | 30 Oct 2025 | 25,000 | 50,519 | - | 265 | 6,625,000 | Common Stock |
| Booz Allen Hamilton Holding Corp (Class A) | Horacio D. Rozanski | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 84.66 per share. | 30 Oct 2025 | 23,800 | 687,745 (0%) | 0% | 84.7 | 2,014,908 | Class A Common Stock |
| Impinj Inc | Chris Diorio | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 23,500 | 0 | - | - | Stock Option (right to buy) | |
| Impinj Inc | Chris Diorio | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.40 per share. | 30 Oct 2025 | 23,500 | 378,005 (1%) | 0% | 22.4 | 526,400 | Common Stock |
| Brandywine Realty Trust | James C. Diggs | Director | Sale of securities on an exchange or to another person at price $ 3.47 per share. | 30 Oct 2025 | 23,190 | 128,672 (0%) | 0% | 3.5 | 80,469 | Common Shares of Beneficial Interest |
| Solstice Advanced Materials | Brian Scott Rudick | SVP, Gen. Counsel and Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 22,559 | 22,559 | - | - | Stock Option (Right to buy) | |
| Micron Tech | Mark J. Murphy | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 226.51 per share. | 30 Oct 2025 | 22,347 | 219,693 (0%) | 0% | 226.5 | 5,061,819 | Common Stock |
| MSC Industrial Direct Co. Inc (Class A) | Mitchell Jacobson | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 83.93 per share. | 30 Oct 2025 | 21,954 | 2,275,322 (5%) | 0% | 83.9 | 1,842,590 | Class A Common Stock |
| Newmont | Natascha Viljoen | President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.67 per share. | 30 Oct 2025 | 21,898 | 138,678 (0%) | 0% | 79.7 | 1,744,614 | Common Stock, $1.60 par value |
| Solstice Advanced Materials | Tina Pierce | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 21,808 | 21,808 | - | - | Stock Option (Right to buy) | |
| Nuvalent Inc (Class A) | Deborah Miller | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.89 per share. | 30 Oct 2025 | 21,800 | 70,886 | - | 6.9 | 150,202 | Class A Common Stock |
| Nuvalent Inc (Class A) | Deborah Miller | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 21,800 | 118,808 | - | - | Stock Option (Right to Buy) | |
| Solstice Advanced Materials | Tina Pierce | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 21,734 | 21,734 | - | - | Stock Option (Right to buy) | |
| Ventas | Debra A. Cafaro | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 65.45 per share. | 30 Oct 2025 | 20,644 | 1,166,339 (0%) | 0% | 65.5 | 1,351,150 | Common Stock |
| Ventas | Debra A. Cafaro | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 20,644 | 430,806 | - | - | Stock Option (Right to Buy) | |
| Ventas | Debra A. Cafaro | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 74.34 per share. | 30 Oct 2025 | 20,644 | 1,145,695 (0%) | 0% | 74.3 | 1,534,720 | Common Stock |
| Qualys Inc | Bruce K. Posey | CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 20,357 | 77,132 (0%) | 0% | 0 | Common Stock | |
| Wolverine World Wide Inc | Amy M. Klimek | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 20,350 | 20,350 | - | - | Restricted Stock Units | |
| Wolverine World Wide Inc | Amy M. Klimek | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 20,350 | 20,350 (0%) | 0% | - | Common Stock | |
| Wolverine World Wide Inc | Christopher E. Hufnagel | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 20,350 | 251,908 (0%) | 0% | - | Common Stock | |
| Wolverine World Wide Inc | Christopher E. Hufnagel | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 20,350 | 20,350 | - | - | Restricted Stock Units | |
| Applovin Corp (Class A) | Victoria Valenzuela | CALO & Corp. Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 20,236 | 290,191 | - | 0 | Class A Common Stock | |
| Applovin Corp (Class A) | Adam Foroughi | Director, CEO & Chairperson, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 20,236 | 2,610,290 | - | 0 | Class A Common Stock | |
| Applovin Corp (Class A) | Vasily Shikin | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 20,236 | 3,380,340 | - | 0 | Class A Common Stock | |
| Applovin Corp (Class A) | Matthew Stumpf | Chief Financial Officer (CFO) | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 20,236 | 201,893 | - | 0 | Class A Common Stock | |
| Iridium Comm Inc | Matthew J. Desch | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 17.33 per share. | 30 Oct 2025 | 20,000 | 1,127,019 (0%) | 0% | 17.3 | 346,600 | Common Stock |
| Petmed Express Inc | Douglas Krulik | CAO and Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 20,000 | 70,000 (0%) | 0% | 0 | Common Stock | |
| Ford Motor | John B. Veihmeyer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 19,812 | 140,914 (0%) | 0% | - | Common Stock, $0.01 par value | |
| Ford Motor | John B. Veihmeyer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 19,812 | 104,830 | - | - | Ford Stock Units | |
| Solstice Advanced Materials | Brian Scott Rudick | SVP, Gen. Counsel and Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 19,724 | 19,724 | - | - | Restricted Stock Units | |
| Solstice Advanced Materials | Jeffrey Harrison Dormo | SVP, Ref. and App. Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 19,724 | 19,724 | - | - | Restricted Stock Units | |
| Solstice Advanced Materials | Simon Mawson | SVP, Elec & Spec Materials | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 19,724 | 19,724 | - | - | Restricted Stock Units | |
| Solstice Advanced Materials | Brian Scott Rudick | SVP, Gen. Counsel and Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 19,570 | 19,570 | - | - | Stock Option (Right to buy) | |
| Reddit Inc (Class A) | Steve Huffman | Director, CEO & President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 18,000 | 512,104 | - | 0 | Class A Common Stock | |
| Reddit Inc (Class A) | Steve Huffman | Director, CEO & President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 18,000 | 1,405,255 | - | - | Stock Option (Right to Buy) | |
| Twist Bioscience Corp | Patrick Finn | President and COO | Sale of securities on an exchange or to another person at price $ 31.44 per share. | 30 Oct 2025 | 17,606 | 268,674 (0%) | 0% | 31.4 | 553,608 | Common Stock |
| Ford Motor | John S. Weinberg | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 16,861 | 95,713 | - | - | Ford Stock Units | |
| Ford Motor | John S. Weinberg | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 16,861 | 196,974 (0%) | 0% | - | Common Stock, $0.01 par value | |
| JBG SMITH Properties | Steven A. Museles | Chief Legal Off. & Corp. Secy | Sale of securities on an exchange or to another person at price $ 19.58 per share. | 30 Oct 2025 | 16,253 | 0 (0%) | 0% | 19.6 | 318,234 | Common Shares |
| Merchants Bancorp | Michael R. Dury | CEO of Merchants Capital | Purchase of securities on an exchange or from another person at price $ 31.64 per share. | 30 Oct 2025 | 15,500 | 138,074 (0%) | 0% | 31.6 | 490,420 | Common Stock |
| JBG SMITH Properties | Steven A. Museles | Chief Legal Off. & Corp. Secy | Sale of securities on an exchange or to another person at price $ 19.41 per share. | 30 Oct 2025 | 15,003 | 16,253 (0%) | 0% | 19.4 | 291,208 | Common Shares |
| Flotek Ind Inc | J. Bond Clement | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 15,000 | 106,504 (0%) | 0% | - | Common Shares | |
| Flotek Ind Inc | J. Bond Clement | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 15,000 | 0 | - | - | Performance Based Restricted Stock Unit | |
| Mirion Tech Inc (Class A) | Brian Schopfer | Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Oct 2025 | 15,000 | 904,432 | - | 0 | Class A Common Stock | |
| Solstice Advanced Materials | Jeffrey Harrison Dormo | SVP, Ref. and App. Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 14,825 | 14,825 | - | - | Stock Option (Right to buy) | |
| FrontView REIT Inc | Ernesto Perez | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 14,802 | 14,802 | - | - | Common Stock | |
| FrontView REIT Inc | Ernesto Perez | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 14,802 | 0 | - | - | OP Units | |
| Solstice Advanced Materials | Jason Michael Clifford | SVP and Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 14,793 | 98,620 | - | - | Restricted Stock Units | |
| Solstice Advanced Materials | Tina Pierce | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 13,899 | 13,899 | - | - | Stock Option (Right to buy) | |
| Solstice Advanced Materials | Tina Pierce | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 13,852 | 13,852 | - | - | Stock Option (Right to buy) | |
| Expedia Group | Robert J. Dzielak | Chief Legal Officer & Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 13,824 | 13,824 | - | - | Restricted Stock Units | |
| Super Micro Computer | David Weigand | SVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 13,000 | 113,188 (0%) | 0% | - | Common Stock | |
| Super Micro Computer | David Weigand | SVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 13,000 | 0 | - | - | Restricted Stock Units | |
| Solstice Advanced Materials | Jeffrey Harrison Dormo | SVP, Ref. and App. Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 12,858 | 12,858 | - | - | Stock Option (Right to buy) | |
| Verra Mobility Corp (Class A) | Jonathan Keyser | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 12,771 | 12,771 | - | - | Restricted Stock Units | |
| NBT Bancorp. Inc | David J. Nasca | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Oct 2025 | 12,255 | 70,655 (0%) | 0% | 0 | NBT Bancorp Inc. Common Stock | |
| PTC Therapeutics Inc | Emma Reeve | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 12,000 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Emma Reeve | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.10 per share. | 30 Oct 2025 | 12,000 | 18,666 (0%) | 0% | 38.1 | 457,200 | Common Stock |
| PTC Therapeutics Inc | Emma Reeve | Director | Sale of securities on an exchange or to another person at price $ 69.50 per share. | 30 Oct 2025 | 12,000 | 6,666 (0%) | 0% | 69.5 | 834,000 | Common Stock |
| Solstice Advanced Materials | Brian Scott Rudick | SVP, Gen. Counsel and Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 11,989 | 11,989 | - | - | Stock Option (Right to buy) | |
| Flotek Ind Inc | Ryan Gillis Ezell | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.75 per share. | 30 Oct 2025 | 11,805 | 167,706 (0%) | 0% | 18.8 | 221,344 | Common Shares |
| Wolverine World Wide Inc | Amy M. Klimek | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 22.32 per share. | 30 Oct 2025 | 11,528 | 0 (0%) | 0% | 22.3 | 257,305 | Common Stock |
| Micron Tech | Mark J. Murphy | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 223.83 per share. | 30 Oct 2025 | 11,382 | 325,391 (0%) | 0% | 223.8 | 2,547,633 | Common Stock |
| Navan Inc Ordinary Shares | Anne Mary Giviskos | Chief Accounting Officer | 30 Oct 2025 | 11,267 | 108,765 | - | 0 | Class A Common Stock | ||
| Ionis Pharma Inc | Joseph H. Wender | Director | Sale of securities on an exchange or to another person at price $ 75.16 per share. | 30 Oct 2025 | 11,200 | 64,035 (0%) | 0% | 75.2 | 841,776 | Common Stock |
| Credo Tech Grp Holding Ltd | William Brennan | Director, Pres & Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 170.27 per share. | 30 Oct 2025 | 11,102 | 1,970,860 | - | 170.3 | 1,890,329 | Ordinary Shares |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share. | 30 Oct 2025 | 11,000 | 47,781 (0%) | 0% | 135.4 | 1,489,620 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 11,000 | 22,000 | - | - | Stock Option | |
| Xylem | Claudia S. Toussaint | EVP, CPSO | Sale of securities on an exchange or to another person at price $ 152.64 per share. | 30 Oct 2025 | 10,421 | 31,250 (0%) | 0% | 152.6 | 1,590,661 | Common Stock |
| Ventas | Debra A. Cafaro | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 10,322 | 113,548 | - | - | Stock Option (Right to Buy) | |
| Ventas | Debra A. Cafaro | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 10,322 | 123,870 | - | - | Stock Option (Right to Buy) | |
| Ventas | Debra A. Cafaro | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 73.74 per share. | 30 Oct 2025 | 10,322 | 1,145,695 (0%) | 0% | 73.7 | 761,096 | Common Stock |
| Ventas | Debra A. Cafaro | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.24 per share. | 30 Oct 2025 | 10,322 | 1,156,017 (0%) | 0% | 63.2 | 652,763 | Common Stock |
| Ventas | Debra A. Cafaro | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 73.98 per share. | 30 Oct 2025 | 10,322 | 1,145,695 (0%) | 0% | 74.0 | 763,595 | Common Stock |
| Ventas | Debra A. Cafaro | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.71 per share. | 30 Oct 2025 | 10,322 | 1,156,017 (0%) | 0% | 73.7 | 760,835 | Common Stock |
| Solstice Advanced Materials | Jeffrey Harrison Dormo | SVP, Ref. and App. Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 10,184 | 10,184 | - | - | Restricted Stock Units | |
| SLM Corp | Peter M. Graham | EVP, CFO & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.61 per share. | 30 Oct 2025 | 10,105 | 110,974 (0%) | 0% | 26.6 | 268,894 | Common Stock |
| JBG SMITH Properties | Scott A. Estes | Director | Sale of securities on an exchange or to another person at price $ 19.87 per share. | 30 Oct 2025 | 10,000 | 20,000 (0%) | 0% | 19.9 | 198,700 | Common Shares |
| Calix Inc | Cory J. Sindelar | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.05 per share. | 30 Oct 2025 | 10,000 | 86,555 (0%) | 0% | 5.1 | 50,500 | Common Stock |
| Calix Inc | Cory J. Sindelar | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 10,000 | 225,000 | - | - | Stock Option (right to buy) | |
| Calix Inc | Cory J. Sindelar | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 10,000 | 235,000 | - | - | Stock Option (right to buy) | |
| Calix Inc | Cory J. Sindelar | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 70.00 per share. | 30 Oct 2025 | 10,000 | 76,555 (0%) | 0% | 70 | 700,000 | Common Stock |
| Calix Inc | Cory J. Sindelar | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.05 per share. | 30 Oct 2025 | 10,000 | 86,555 (0%) | 0% | 5.1 | 50,500 | Common Stock |
| Calix Inc | Cory J. Sindelar | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 65.00 per share. | 30 Oct 2025 | 10,000 | 76,555 (0%) | 0% | 65 | 650,000 | Common Stock |
| Fiserv | Lance M. Fritz | Director | Purchase of securities on an exchange or from another person at price $ 65.18 per share. | 30 Oct 2025 | 10,000 | 13,086 (0%) | 0% | 65.2 | 651,800 | Common Stock |
| QuinStreet Inc | David J. Pauldine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 9,938 | 186,765 (0%) | 0% | 0 | Common Stock | |
| QuinStreet Inc | Stuart M. Huizinga | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 9,938 | 181,861 (0%) | 0% | 0 | Common Stock | |
| QuinStreet Inc | Andrew T. Sheehan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 9,938 | 17,670 (0%) | 0% | 0 | Common Stock | |
| QuinStreet Inc | James R. Simons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 9,938 | 75,728 (0%) | 0% | 0 | Common Stock | |
| QuinStreet Inc | Hillary B. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 9,938 | 63,959 (0%) | 0% | 0 | Common Stock | |
| QuinStreet Inc | Matthew Glickman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 9,938 | 123,078 (0%) | 0% | 0 | Common Stock | |
| QuinStreet Inc | Asmau Ahmed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 9,938 | 64,979 (0%) | 0% | 0 | Common Stock | |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.66 per share. | 30 Oct 2025 | 9,748 | 18,257 (0%) | 0% | 30.7 | 298,874 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 9,748 | 0 | - | - | Stock Options (Right to Buy) | |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 115.24 per share. | 30 Oct 2025 | 9,748 | 8,509 (0%) | 0% | 115.2 | 1,123,398 | Common Stock |
| PureCycle Tech Inc | Jeffrey Fieler | Director | 30 Oct 2025 | 9,675 | 1,973,428 | - | 0 | Common Stock | ||
| Matador Resources Co | Joseph Wm. Foran | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 39.78 per share. | 30 Oct 2025 | 9,500 | 17,525 (0%) | 0% | 39.8 | 377,910 | Common Stock |
| Nuvalent Inc (Class A) | Deborah Miller | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 104.78 per share. | 30 Oct 2025 | 9,382 | 49,086 | - | 104.8 | 983,046 | Class A Common Stock |
| Applied Digital Corp | Richard N. Nottenburg | Director | Sale of securities on an exchange or to another person at price $ 35.91 per share. | 30 Oct 2025 | 9,375 | 249,237 | - | 35.9 | 336,656 | Common Stock |
| Solstice Advanced Materials | Simon Mawson | SVP, Elec & Spec Materials | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 9,312 | 9,312 | - | - | Stock Option (Right to buy) | |
| Solstice Advanced Materials | Tina Pierce | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 9,075 | 9,075 | - | - | Restricted Stock Units | |
| Solstice Advanced Materials | Tina Pierce | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 9,045 | 9,045 | - | - | Restricted Stock Units | |
| Nucor | Allen C. Behr | Executive Vice President | Sale of securities on an exchange or to another person at price $ 151.28 per share. | 30 Oct 2025 | 9,042 | 73,661 (0%) | 0% | 151.3 | 1,367,902 | Common Stock |
| Inseego Corp | Stephen J. Bye | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 8,879 | 8,879 (0%) | 0% | 0 | Common Stock | |
| Inseego Corp | Nabeel Anwar Bukhari Syed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 8,879 | 8,879 (0%) | 0% | 0 | Common Stock | |
| Wolverine World Wide Inc | Amy M. Klimek | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.05 per share. | 30 Oct 2025 | 8,822 | 11,528 (0%) | 0% | 23.0 | 203,347 | Common Stock |
| Wolverine World Wide Inc | Christopher E. Hufnagel | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.05 per share. | 30 Oct 2025 | 8,822 | 243,086 (0%) | 0% | 23.0 | 203,347 | Common Stock |
| Solstice Advanced Materials | Tina Pierce | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 8,636 | 8,636 | - | - | Stock Option (Right to buy) | |
| Solstice Advanced Materials | Tina Pierce | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 8,607 | 8,607 | - | - | Stock Option (Right to buy) | |
| Simmons First National Corp (Class A) | Steven A. Cosse | Director | Purchase of securities on an exchange or from another person at price $ 17.44 per share. | 30 Oct 2025 | 8,603 | 113,652 (0%) | 0% | 17.4 | 150,036 | SFNC Common Stock |
| Ionis Pharma Inc | Joseph H. Wender | Director | Sale of securities on an exchange or to another person at price $ 73.16 per share. | 30 Oct 2025 | 8,341 | 81,210 (0%) | 0% | 73.2 | 610,228 | Common Stock |
| Credo Tech Grp Holding Ltd | William Brennan | Director, Pres & Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 171.23 per share. | 30 Oct 2025 | 8,310 | 1,962,550 | - | 171.2 | 1,422,895 | Ordinary Shares |
| Solstice Advanced Materials | Jeffrey Harrison Dormo | SVP, Ref. and App. Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 8,148 | 8,148 | - | - | Restricted Stock Units | |
| Flotek Ind Inc | Ryan Gillis Ezell | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.75 per share. | 30 Oct 2025 | 7,870 | 149,511 (0%) | 0% | 18.8 | 147,563 | Common Shares |
| QuinStreet Inc | Andrew T. Sheehan | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Oct 2025 | 7,732 | 9,938 (0%) | 0% | 0 | Common Stock | |
| QuinStreet Inc | Andrew T. Sheehan | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Oct 2025 | 7,732 | 55,218 (0%) | 0% | 0 | Common Stock | |
| Solstice Advanced Materials | Simon Mawson | SVP, Elec & Spec Materials | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 7,691 | 7,691 | - | - | Stock Option (Right to buy) | |
| Hayward Holdings Inc | Kevin D. Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 7,550 | 3,208,079 | - | 0 | Common Stock | |
| Entergy | Jason Chapman | SVP Chief Tech & Bus Servs Off | Sale of securities on an exchange or to another person at price $ 96.45 per share. | 30 Oct 2025 | 7,542 | 25,976 (0%) | 0% | 96.5 | 727,426 | Common Stock |
| Snowflake Inc (Class A) | Benoit Dageville | Director, Founder and Chief Architect | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Oct 2025 | 7,500 | 3,066,555 | - | 0 | Common Stock | |
| Seagate Tech | Kian Fatt Chong | EVP Global Operations | Sale of securities on an exchange or to another person at price $ 272.14 per share. | 30 Oct 2025 | 7,078 | 0 (0%) | 0% | 272.1 | 1,926,209 | Ordinary Shares |
| Twist Bioscience Corp | Paula Green | SVP of Human Resources | Sale of securities on an exchange or to another person at price $ 31.44 per share. | 30 Oct 2025 | 6,920 | 143,271 (0%) | 0% | 31.4 | 217,595 | Common Stock |
| Solstice Advanced Materials | Simon Mawson | SVP, Elec & Spec Materials | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 6,884 | 6,884 | - | - | Restricted Stock Units | |
| Solstice Advanced Materials | Brian Scott Rudick | SVP, Gen. Counsel and Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 6,843 | 6,843 | - | - | Stock Option (Right to buy) | |
| Solstice Advanced Materials | Simon Mawson | SVP, Elec & Spec Materials | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 6,779 | 6,779 | - | - | Restricted Stock Units | |
| Credo Tech Grp Holding Ltd | William Brennan | Director, Pres & Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 173.25 per share. | 30 Oct 2025 | 6,778 | 1,949,363 | - | 173.2 | 1,174,280 | Ordinary Shares |
| Pearson PLC (ADR) | Omid R. Kordestani | Non-Executive Director,Chairman | Purchase of securities on an exchange or from another person at price $ 14.06 per share. | 30 Oct 2025 | 6,746 | 98,603 (0%) | 0% | 14.1 | 94,882 | Ords 0.25p |
| Amalgamated Fin Corp | Julie Kelly | Director | Sale of securities on an exchange or to another person at price $ 27.34 per share. | 30 Oct 2025 | 6,697 | 16,763 (0%) | 0% | 27.3 | 183,107 | Common Stock |
| Amalgamated Fin Corp | Edgar Romney | Director | Sale of securities on an exchange or to another person at price $ 27.34 per share. | 30 Oct 2025 | 6,697 | 16,763 (0%) | 0% | 27.3 | 183,112 | Common Stock |
| Super Micro Computer | David Weigand | SVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.37 per share. | 30 Oct 2025 | 6,602 | 106,586 (0%) | 0% | 50.4 | 332,543 | Common Stock |
| Twist Bioscience Corp | Dennis Cho | See Remarks | Sale of securities on an exchange or to another person at price $ 31.44 per share. | 30 Oct 2025 | 6,515 | 121,713 (0%) | 0% | 31.4 | 204,860 | Common Stock |
| Medpace Holdings Inc | Fred B. Davenport | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.99 per share. | 30 Oct 2025 | 6,472 | 9,470 (0%) | 0% | 55.0 | 355,895 | Common Stock |
| Medpace Holdings Inc | Fred B. Davenport | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 6,472 | 0 | - | - | Stock Option (Right to Buy) | |
| Credo Tech Grp Holding Ltd | William Brennan | Director, Pres & Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 172.30 per share. | 30 Oct 2025 | 6,409 | 1,956,141 | - | 172.3 | 1,104,256 | Ordinary Shares |
| Duluth Holdings Inc (Class B) | Scott K. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 6,406 | 129,160 (0%) | 0% | - | Class B Common Stock | |
| Cardlytics Inc | Srishti A. Gupta | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 6,148 | 0 | - | - | Restricted Stock Unit | |
| Cardlytics Inc | Srishti A. Gupta | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 6,148 | 6,148 (0%) | 0% | - | Common Stock | |
| Flotek Ind Inc | Amy E. Blakeway | SVP, GC and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 6,000 | 0 | - | - | Performance Based Restricted Stock Unit | |
| Flotek Ind Inc | Amy E. Blakeway | SVP, GC and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 6,000 | 23,311 (0%) | 0% | - | Common Stock | |
| Super Micro Computer | Charles Liang | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 6,000 | 609,657 (1%) | 0% | - | Common Stock | |
| Super Micro Computer | Charles Liang | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 6,000 | 0 | - | - | Restricted Stock Units | |
| Super Micro Computer | Chiu-Chu Liu Liang | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 6,000 | 609,657 (1%) | 0% | - | Common Stock | |
| Super Micro Computer | Chiu-Chu Liu Liang | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 6,000 | 0 | - | - | Restricted Stock Units | |
| Super Micro Computer | Don Clegg | SVP, Worldwide Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 6,000 | 48,579 (0%) | 0% | - | Common Stock | |
| Super Micro Computer | Don Clegg | SVP, Worldwide Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 6,000 | 0 | - | - | Restricted Stock Units | |
| Ionis Pharma Inc | Joseph H. Wender | Director | Sale of securities on an exchange or to another person at price $ 73.85 per share. | 30 Oct 2025 | 5,975 | 75,235 (0%) | 0% | 73.9 | 441,254 | Common Stock |
| Medpace Holdings Inc | Fred B. Davenport | Director | Sale of securities on an exchange or to another person at price $ 581.88 per share. | 30 Oct 2025 | 5,972 | 3,498 (0%) | 0% | 581.9 | 3,474,987 | Common Stock |
| Flotek Ind Inc | J. Bond Clement | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.75 per share. | 30 Oct 2025 | 5,903 | 100,601 (0%) | 0% | 18.7 | 110,681 | Common Shares |
| Solstice Advanced Materials | Tina Pierce | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 5,874 | 5,874 | - | - | Restricted Stock Units | |
| Solstice Advanced Materials | Tina Pierce | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 5,854 | 5,854 | - | - | Restricted Stock Units | |
| Solstice Advanced Materials | Tina Pierce | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 5,767 | 5,767 | - | - | Restricted Stock Units | |
| Solstice Advanced Materials | Tina Pierce | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 5,747 | 5,747 | - | - | Restricted Stock Units | |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 31.44 per share. | 30 Oct 2025 | 5,517 | 111,008 (0%) | 0% | 31.4 | 173,478 | Common Stock |
| LSB Ind Inc | Cheryl Maguire | EVP and CFO | Sale or transfer of securities back to the company at price $ 9.75 per share. | 30 Oct 2025 | 5,400 | 227,870 (0%) | 0% | 9.8 | 52,650 | Common Stock |
| Twin Disc Incorporated | David W. Johnson | Director | Grant, award, or other acquisition of securities at price $ 14.88 per share. | 30 Oct 2025 | 5,378 | 74,358 (0%) | 0% | 14.9 | 79,998 | COMMON STOCK |
| Twin Disc Incorporated | Michael Doar | Director | Grant, award, or other acquisition of securities at price $ 14.88 per share. | 30 Oct 2025 | 5,378 | 127,509 (0%) | 0% | 14.9 | 79,998 | COMMON STOCK |
| Twin Disc Incorporated | Michael C. Smiley | Director | Grant, award, or other acquisition of securities at price $ 14.88 per share. | 30 Oct 2025 | 5,378 | 74,746 (0%) | 0% | 14.9 | 79,998 | COMMON STOCK |
| Twin Disc Incorporated | Janet P. Giesselman | Director | Grant, award, or other acquisition of securities at price $ 14.88 per share. | 30 Oct 2025 | 5,378 | 62,610 (0%) | 0% | 14.9 | 79,998 | COMMON STOCK |
| Twin Disc Incorporated | Kevin M. Olsen | Director | Grant, award, or other acquisition of securities at price $ 14.88 per share. | 30 Oct 2025 | 5,378 | 26,066 (0%) | 0% | 14.9 | 79,998 | COMMON STOCK |
| Duluth Holdings Inc (Class B) | Janet H. Kennedy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 5,339 | 105,903 (0%) | 0% | - | Class B Common Stock | |
| Solstice Advanced Materials | Tina Pierce | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 5,281 | 5,281 | - | - | Restricted Stock Units | |
| Solstice Advanced Materials | Tina Pierce | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 5,263 | 5,263 | - | - | Restricted Stock Units | |
| Solstice Advanced Materials | Tina Pierce | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 5,223 | 5,223 | - | - | Restricted Stock Units | |
| Solstice Advanced Materials | Tina Pierce | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 5,205 | 5,205 | - | - | Restricted Stock Units | |
| Solstice Advanced Materials | Brian Scott Rudick | SVP, Gen. Counsel and Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 5,176 | 5,176 | - | - | Restricted Stock Units | |
| Entergy | Jason Chapman | SVP Chief Tech & Bus Servs Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 5,140 | 10,280 | - | - | Employee Stock Option (Right to Buy) | |
| Entergy | Jason Chapman | SVP Chief Tech & Bus Servs Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 49.54 per share. | 30 Oct 2025 | 5,140 | 33,518 (0%) | 0% | 49.5 | 254,636 | Common Stock |
| Micron Tech | Mark J. Murphy | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 222.96 per share. | 30 Oct 2025 | 5,100 | 336,773 (0%) | 0% | 223.0 | 1,137,096 | Common Stock |
| Solstice Advanced Materials | Brian Scott Rudick | SVP, Gen. Counsel and Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 5,069 | 5,069 | - | - | Restricted Stock Units | |
| Cytokinetics Inc | Robert I. Blum | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 62.86 per share. | 30 Oct 2025 | 5,000 | 358,108 (0%) | 0% | 62.9 | 314,300 | Common Stock |
| Applied Digital Corp | Richard N. Nottenburg | Director | Sale of securities on an exchange or to another person at price $ 34.80 per share. | 30 Oct 2025 | 5,000 | 258,612 | - | 34.8 | 174,000 | Common Stock |
| PayPal | Suzan Kereere | President, Global Markets | Sale of securities on an exchange or to another person at price $ 69.52 per share. | 30 Oct 2025 | 5,000 | 43,483 (0%) | 0% | 69.5 | 347,622 | Common Stock |
| Super Micro Computer | Yih-Shyan Liaw | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 5,000 | 0 | - | - | Restricted Stock Units | |
| Super Micro Computer | Yih-Shyan Liaw | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 5,000 | 82,963 (0%) | 0% | - | Common Stock | |
| Super Micro Computer | George Kao | SVP, OPERATIONS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 5,000 | 0 | - | - | Restricted Stock Units | |
| Super Micro Computer | George Kao | SVP, OPERATIONS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 5,000 | 26,820 (0%) | 0% | - | Common Stock | |
| Solstice Advanced Materials | Simon Mawson | SVP, Elec & Spec Materials | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 4,833 | 4,833 | - | - | Stock Option (Right to buy) | |
| Amalgamated Fin Corp | Julie Kelly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.00 per share. | 30 Oct 2025 | 4,820 | 21,590 (0%) | 0% | 12 | 57,840 | Common Stock |
| Amalgamated Fin Corp | Julie Kelly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 4,820 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Amalgamated Fin Corp | Edgar Romney | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.00 per share. | 30 Oct 2025 | 4,820 | 21,590 (0%) | 0% | 12 | 57,840 | Common Stock |
| Amalgamated Fin Corp | Edgar Romney | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 4,820 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Solstice Advanced Materials | Jeffrey Harrison Dormo | SVP, Ref. and App. Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 4,812 | 4,812 | - | - | Stock Option (Right to buy) | |
| Solstice Advanced Materials | Simon Mawson | SVP, Elec & Spec Materials | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 4,755 | 4,755 | - | - | Restricted Stock Units | |
| Solstice Advanced Materials | Brian Scott Rudick | SVP, Gen. Counsel and Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 4,687 | 4,687 | - | - | Restricted Stock Units | |
| Reddit Inc (Class A) | Steve Huffman | Director, CEO & President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 188.04 per share. | 30 Oct 2025 | 4,333 | 507,771 | - | 188.0 | 814,777 | Class A Common Stock |
| Arcus Biosciences Inc | Juan Carlos Jaen | President | Sale of securities on an exchange or to another person at price $ 20.32 per share. | 30 Oct 2025 | 4,314 | 1,087,060 (2%) | 0% | 20.3 | 87,650 | Common Stock |
| Solstice Advanced Materials | Brian Scott Rudick | SVP, Gen. Counsel and Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 4,266 | 4,266 | - | - | Restricted Stock Units | |
| Amalgamated Fin Corp | Julie Kelly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 4,220 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Amalgamated Fin Corp | Julie Kelly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.75 per share. | 30 Oct 2025 | 4,220 | 23,470 (0%) | 0% | 13.8 | 58,025 | Common Stock |
| Amalgamated Fin Corp | Edgar Romney | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 4,220 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Amalgamated Fin Corp | Edgar Romney | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.75 per share. | 30 Oct 2025 | 4,220 | 23,470 (0%) | 0% | 13.8 | 58,025 | Common Stock |
| Annexon Inc | William H. Carson | Director | Purchase of securities on an exchange or from another person at price $ 3.17 per share. | 30 Oct 2025 | 4,115 | 46,175 | - | 3.2 | 13,045 | Common Stock |
| Nurix Therapeutics Inc | Gwenn Hansen | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 12.80 per share. | 30 Oct 2025 | 4,087 | 76,751 | - | 12.8 | 52,300 | Common Stock |
| Credo Tech Grp Holding Ltd | William Brennan | Director, Pres & Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 174.13 per share. | 30 Oct 2025 | 4,029 | 1,945,334 | - | 174.1 | 701,553 | Ordinary Shares |
| Western Alliance Bancorp | Dale M. Gibbons | Vice Chairman and CFO | Purchase of securities on an exchange or from another person at price $ 77.00 per share. | 30 Oct 2025 | 4,000 | 300,358 (0%) | 0% | 77 | 308,000 | Common Stock |
| Nuvalent Inc (Class A) | Darlene Noci | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 4,000 | 122,329 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Darlene Noci | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.85 per share. | 30 Oct 2025 | 4,000 | 52,034 | - | 27.9 | 111,400 | Class A Common Stock |
| Amalgamated Fin Corp | Julie Kelly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 3,960 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Amalgamated Fin Corp | Julie Kelly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.65 per share. | 30 Oct 2025 | 3,960 | 25,382 (0%) | 0% | 14.7 | 58,014 | Common Stock |
| Amalgamated Fin Corp | Edgar Romney | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 3,960 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Amalgamated Fin Corp | Edgar Romney | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.65 per share. | 30 Oct 2025 | 3,960 | 25,382 (0%) | 0% | 14.7 | 58,014 | Common Stock |
| Flotek Ind Inc | J. Bond Clement | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.75 per share. | 30 Oct 2025 | 3,935 | 91,504 (0%) | 0% | 18.7 | 73,781 | Common Shares |
| Credo Tech Grp Holding Ltd | William Brennan | Director, Pres & Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 170.27 per share. | 30 Oct 2025 | 3,897 | 330,339 | - | 170.3 | 663,538 | Ordinary Shares |
| Reddit Inc (Class A) | Steve Huffman | Director, CEO & President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 188.98 per share. | 30 Oct 2025 | 3,873 | 503,898 | - | 189.0 | 731,920 | Class A Common Stock |
| Micron Tech | Mark J. Murphy | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 221.64 per share. | 30 Oct 2025 | 3,820 | 341,873 (0%) | 0% | 221.6 | 846,665 | Common Stock |
| Kinder Morgan (Class P) | Amy W. Chronis | Director | Purchase of securities on an exchange or from another person at price $ 26.22 per share. | 30 Oct 2025 | 3,800 | 39,051 (0%) | 0% | 26.2 | 99,655 | Class P Common Stock |
| Bio-Techne | John L. Higgins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 3,777 | 3,777 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne | Joseph D. Keegan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 3,777 | 3,777 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne | Robert V. Baumgartner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 3,777 | 3,777 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne | Julie L. Bushman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 3,777 | 3,777 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne | Rupert Vessey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 3,777 | 3,777 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne | Alpna Seth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 3,777 | 3,777 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne | Judith Klimovsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 3,777 | 3,777 | - | - | Stock Option (Right to Buy) | |
| Bio-Techne | Amy Herr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 3,777 | 3,777 | - | - | Stock Option (Right to Buy) | |
| Nurix Therapeutics Inc | Gwenn Hansen | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 3,750 | 77,980 | - | 0 | Common Stock | |
| Nurix Therapeutics Inc | Gwenn Hansen | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 3,750 | 22,500 | - | - | Restricted Stock Units | |
| Nurix Therapeutics Inc | Christine Ring | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 3,750 | 22,500 | - | - | Restricted Stock Units | |
| Nurix Therapeutics Inc | Christine Ring | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 3,750 | 51,683 | - | 0 | Common Stock | |
| Nurix Therapeutics Inc | Hans van Houte | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 3,750 | 22,500 | - | - | Restricted Stock Units | |
| Nurix Therapeutics Inc | Hans van Houte | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 3,750 | 44,148 | - | 0 | Common Stock | |
| Nuvalent Inc (Class A) | Deborah Miller | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 102.88 per share. | 30 Oct 2025 | 3,733 | 61,959 | - | 102.9 | 384,051 | Class A Common Stock |
| PTC Therapeutics Inc | Emma Reeve | Director | Sale of securities on an exchange or to another person at price $ 69.50 per share. | 30 Oct 2025 | 3,666 | 6,666 (0%) | 0% | 69.5 | 254,787 | Common Stock |
| Credo Tech Grp Holding Ltd | William Brennan | Director, Pres & Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 167.32 per share. | 30 Oct 2025 | 3,655 | 1,986,508 | - | 167.3 | 611,555 | Ordinary Shares |
| Nurix Therapeutics Inc | Christine Ring | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 12.80 per share. | 30 Oct 2025 | 3,644 | 50,897 | - | 12.8 | 46,631 | Common Stock |
| Nuvalent Inc (Class A) | Deborah Miller | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 103.90 per share. | 30 Oct 2025 | 3,491 | 58,468 | - | 103.9 | 362,715 | Class A Common Stock |
| Credo Tech Grp Holding Ltd | William Brennan | Director, Pres & Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 171.23 per share. | 30 Oct 2025 | 3,469 | 326,870 | - | 171.2 | 594,006 | Ordinary Shares |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 449.46 per share. | 30 Oct 2025 | 3,441 | 42,555 (0%) | 0% | 449.5 | 1,546,606 | Common Stock |
| Solstice Advanced Materials | Jeffrey Harrison Dormo | SVP, Ref. and App. Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 3,403 | 3,403 | - | - | Restricted Stock Units | |
| Avidia Bancorp Inc | Robert D. Cozzone | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 15.03 per share. | 30 Oct 2025 | 3,325 | 46,472 | - | 15.0 | 49,987 | Common Stock |
| Wesbanco Inc | Zahid Afzal | Director | Purchase of securities on an exchange or from another person at price $ 30.11 per share. | 30 Oct 2025 | 3,319 | 13,221 (0%) | 0% | 30.1 | 99,940 | Common Stock |
| Solstice Advanced Materials | Tina Pierce | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 3,256 | 3,256 | - | - | Restricted Stock Units | |
| Solstice Advanced Materials | Tina Pierce | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 3,245 | 3,245 | - | - | Restricted Stock Units | |
| Super Micro Computer | Charles Liang | Director, President and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.37 per share. | 30 Oct 2025 | 3,231 | 606,426 (1%) | 0% | 50.4 | 162,745 | Common Stock |
| Super Micro Computer | Chiu-Chu Liu Liang | Director, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.37 per share. | 30 Oct 2025 | 3,231 | 606,426 (1%) | 0% | 50.4 | 162,745 | Common Stock |
| Celestica Inc | Laurette T. Koellner | Director | Purchase of securities on an exchange or from another person at price $ 341.96 per share. | 30 Oct 2025 | 3,227 | 4,527 (0%) | 0% | 342.0 | 1,103,505 | Common Shares |
| Nurix Therapeutics Inc | Gwenn Hansen | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 3,207 | 72,230 | - | 0 | Common Stock | |
| Nurix Therapeutics Inc | Gwenn Hansen | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 3,207 | 3,207 | - | - | Restricted Stock Units | |
| Reddit Inc (Class A) | Steve Huffman | Director, CEO & President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 190.07 per share. | 30 Oct 2025 | 3,205 | 500,693 | - | 190.1 | 609,174 | Class A Common Stock |
| Solstice Advanced Materials | Jeffrey Harrison Dormo | SVP, Ref. and App. Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 3,170 | 3,170 | - | - | Restricted Stock Units | |
| Solstice Advanced Materials | Tina Pierce | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 3,136 | 3,136 | - | - | Restricted Stock Units | |
| Nurix Therapeutics Inc | Hans van Houte | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.80 per share. | 30 Oct 2025 | 3,130 | 43,876 | - | 12.8 | 40,054 | Common Stock |
| Integer Holdings Corp | Payman Khales | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 64.94 per share. | 30 Oct 2025 | 3,127 | 22,865 (0%) | 0% | 64.9 | 203,067 | Common Stock |
| Solstice Advanced Materials | Tina Pierce | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 3,125 | 3,125 | - | - | Restricted Stock Units | |
| Solstice Advanced Materials | Jeffrey Harrison Dormo | SVP, Ref. and App. Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 3,083 | 3,083 | - | - | Restricted Stock Units | |
| Super Micro Computer | Don Clegg | SVP, Worldwide Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.37 per share. | 30 Oct 2025 | 3,047 | 45,532 (0%) | 0% | 50.4 | 153,477 | Common Stock |
| PureCycle Tech Inc | Jeffrey Fieler | Director | 30 Oct 2025 | 2,902 | 1,970,526 | - | 11.3 | 32,909 | Common Stock | |
| Nurix Therapeutics Inc | Hans van Houte | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 2,886 | 38,398 | - | 0 | Common Stock | |
| Nurix Therapeutics Inc | Hans van Houte | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 2,886 | 2,887 | - | - | Restricted Stock Units | |
| Nurix Therapeutics Inc | Gwenn Hansen | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 2,858 | 28,584 | - | - | Restricted Stock Units | |
| Nurix Therapeutics Inc | Gwenn Hansen | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 2,858 | 80,838 | - | 0 | Common Stock | |
| Nurix Therapeutics Inc | Christine Ring | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 2,858 | 28,584 | - | - | Restricted Stock Units | |
| Nurix Therapeutics Inc | Christine Ring | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 2,858 | 54,541 | - | 0 | Common Stock | |
| Nurix Therapeutics Inc | Hans van Houte | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 2,858 | 28,584 | - | - | Restricted Stock Units | |
| Nurix Therapeutics Inc | Hans van Houte | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 2,858 | 47,006 | - | 0 | Common Stock | |
| Solstice Advanced Materials | Jeffrey Harrison Dormo | SVP, Ref. and App. Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 2,794 | 2,794 | - | - | Stock Option (Right to buy) | |
| Corning | Jaymin Amin | SVP and Chief Tech. Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Oct 2025 | 2,650 | 86,072 (0%) | 0% | 0 | Common Stock | |
| Healthstream Inc | Trisha L. Coady | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 2,566 | 33,155 (0%) | 0% | 0 | Common Stock Holding | |
| Healthstream Inc | Trisha L. Coady | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 2,566 | 2,995 | - | - | Restricted Share Units | |
| Super Micro Computer | Yih-Shyan Liaw | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.37 per share. | 30 Oct 2025 | 2,540 | 80,423 (0%) | 0% | 50.4 | 127,940 | Common Stock |
| Super Micro Computer | George Kao | SVP, OPERATIONS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.37 per share. | 30 Oct 2025 | 2,540 | 24,280 (0%) | 0% | 50.4 | 127,940 | Common Stock |
| Solstice Advanced Materials | Simon Mawson | SVP, Elec & Spec Materials | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 2,507 | 2,507 | - | - | Stock Option (Right to buy) | |
| Atlassian Corp (Class A) | Michael Cannon-Brookes | Director, CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 161.01 per share. | 30 Oct 2025 | 2,501 | 323,880 (0%) | 0% | 161.0 | 402,688 | Class A Common Stock |
| Atlassian Corp (Class A) | Scott Farquhar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 161.01 per share. | 30 Oct 2025 | 2,500 | 325,195 (0%) | 0% | 161.0 | 402,527 | Class A Common Stock |
| Reddit Inc (Class A) | Steve Huffman | Director, CEO & President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 191.16 per share. | 30 Oct 2025 | 2,500 | 498,193 | - | 191.2 | 477,900 | Class A Common Stock |
| Ionis Pharma Inc | Joseph H. Wender | Director | Sale of securities on an exchange or to another person at price $ 72.19 per share. | 30 Oct 2025 | 2,484 | 89,551 (0%) | 0% | 72.2 | 179,320 | Common Stock |
| Solstice Advanced Materials | Rose Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 2,474 | 2,474 | - | - | Restricted Stock Units | |
| Credo Tech Grp Holding Ltd | William Brennan | Director, Pres & Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 169.36 per share. | 30 Oct 2025 | 2,444 | 1,981,962 | - | 169.4 | 413,906 | Ordinary Shares |
| Entergy | Jason Chapman | SVP Chief Tech & Bus Servs Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.80 per share. | 30 Oct 2025 | 2,402 | 28,378 (0%) | 0% | 54.8 | 131,630 | Common Stock |
| Entergy | Jason Chapman | SVP Chief Tech & Bus Servs Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 2,402 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Credo Tech Grp Holding Ltd | William Brennan | Director, Pres & Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 172.30 per share. | 30 Oct 2025 | 2,380 | 324,490 | - | 172.3 | 410,066 | Ordinary Shares |
| Flotek Ind Inc | Amy E. Blakeway | SVP, GC and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.75 per share. | 30 Oct 2025 | 2,361 | 20,950 (0%) | 0% | 18.8 | 44,269 | Common Stock |
| Amalgamated Fin Corp | Julie Kelly | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.56 per share. | 30 Oct 2025 | 2,340 | 19,250 (0%) | 0% | 27.6 | 64,485 | Common Stock |
| Amalgamated Fin Corp | Edgar Romney | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.56 per share. | 30 Oct 2025 | 2,340 | 19,250 (0%) | 0% | 27.6 | 64,485 | Common Stock |
| Credo Tech Grp Holding Ltd | William Brennan | Director, Pres & Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 166.37 per share. | 30 Oct 2025 | 2,339 | 1,990,163 | - | 166.4 | 389,148 | Ordinary Shares |
| Farmers & Merchants Bancorp Inc | Steven J. Planson | Director | Purchase of securities on an exchange or from another person at price $ 23.42 per share. | 30 Oct 2025 | 2,329 | 32,165 (0%) | 0% | 23.4 | 54,545 | Common Stock |
| Solstice Advanced Materials | Jeffrey Harrison Dormo | SVP, Ref. and App. Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 2,313 | 2,313 | - | - | Restricted Stock Units | |
| Amalgamated Fin Corp | Julie Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 2,311 | 19,074 (0%) | 0% | 0 | Common Stock | |
| Amalgamated Fin Corp | Edgar Romney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 2,311 | 19,074 (0%) | 0% | 0 | Common Stock | |
| Solstice Advanced Materials | Brian Scott Rudick | SVP, Gen. Counsel and Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 2,300 | 2,300 | - | - | Restricted Stock Units | |
| Salesforce | Marc Benioff | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 161.50 per share. | 30 Oct 2025 | 2,250 | 11,913,821 (1%) | 0% | 161.5 | 363,375 | Common Stock |
| Salesforce | Marc Benioff | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 2,250 | 2,372 | - | - | Non-qualified Stock Option (Right to Buy) | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 450.64 per share. | 30 Oct 2025 | 2,247 | 40,308 (0%) | 0% | 450.6 | 1,012,579 | Common Stock |
| Nuvalent Inc (Class A) | Deborah Miller | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 102.00 per share. | 30 Oct 2025 | 2,121 | 65,692 | - | 102 | 216,342 | Class A Common Stock |
| Credo Tech Grp Holding Ltd | William Brennan | Director, Pres & Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 173.28 per share. | 30 Oct 2025 | 2,121 | 322,369 | - | 173.3 | 367,518 | Ordinary Shares |
| Credo Tech Grp Holding Ltd | William Brennan | Director, Pres & Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 168.25 per share. | 30 Oct 2025 | 2,102 | 1,984,406 | - | 168.2 | 353,656 | Ordinary Shares |
| Nucor | Stephen D. Laxton | CFO and EVP | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Oct 2025 | 2,061 | 90,177 (0%) | 0% | 0 | Common Stock | |
| First Bancorp PR | Felix M. Villamil | Director | Grant, award, or other acquisition of securities at price $ 19.48 per share. | 30 Oct 2025 | 2,053 | 19,060 (0%) | 0% | 19.5 | 39,992 | First BanCorp Common Stock, par value $0.10 per share |
| Amalgamated Fin Corp | Julie Kelly | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.56 per share. | 30 Oct 2025 | 2,048 | 21,422 (0%) | 0% | 27.6 | 56,438 | Common Stock |
| Amalgamated Fin Corp | Edgar Romney | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.56 per share. | 30 Oct 2025 | 2,048 | 21,422 (0%) | 0% | 27.6 | 56,438 | Common Stock |
| Solstice Advanced Materials | Simon Mawson | SVP, Elec & Spec Materials | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 2,045 | 2,045 | - | - | Restricted Stock Units | |
| Solstice Advanced Materials | Jeffrey Harrison Dormo | SVP, Ref. and App. Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 2,036 | 2,036 | - | - | Restricted Stock Units | |
| Solstice Advanced Materials | Simon Mawson | SVP, Elec & Spec Materials | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2025 | 2,036 | 2,036 | - | - | Restricted Stock Units | |
| Atlassian Corp (Class A) | Scott Farquhar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 162.26 per share. | 30 Oct 2025 | 2,031 | 321,930 (0%) | 0% | 162.3 | 329,548 | Class A Common Stock |
| Atlassian Corp (Class A) | Michael Cannon-Brookes | Director, CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 162.26 per share. | 30 Oct 2025 | 2,030 | 326,381 (0%) | 0% | 162.3 | 329,386 | Class A Common Stock |
| Nurix Therapeutics Inc | Gwenn Hansen | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 2,000 | 74,230 | - | 0 | Common Stock | |
| Nurix Therapeutics Inc | Gwenn Hansen | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 2,000 | 4,000 | - | - | Restricted Stock Units | |
| Nurix Therapeutics Inc | Christine Ring | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 2,000 | 4,000 | - | - | Restricted Stock Units | |
| Nurix Therapeutics Inc | Christine Ring | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 2,000 | 47,933 | - | 0 | Common Stock | |
| Nurix Therapeutics Inc | Hans van Houte | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 2,000 | 40,398 | - | 0 | Common Stock | |
| Nurix Therapeutics Inc | Hans van Houte | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 2,000 | 4,000 | - | - | Restricted Stock Units | |
| Dime Community Bancshares Inc | Raymond A. Nielsen | Director | Sale of securities on an exchange or to another person at price $ 26.61 per share. | 30 Oct 2025 | 2,000 | 36,184 (0%) | 0% | 26.6 | 53,220 | Common Stock |
| Dime Community Bancshares Inc | Raymond A. Nielsen | Director | Sale of securities on an exchange or to another person at price $ 26.28 per share. | 30 Oct 2025 | 2,000 | 34,184 (0%) | 0% | 26.3 | 52,560 | Common Stock |
| Forestar Grp Inc - Ordinary Shares New | Samuel R. Fuller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 2,000 | 29,359 (0%) | 0% | 0 | Common Stock | |
| Forestar Grp Inc - Ordinary Shares New | Samuel R. Fuller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 2,000 | 2,000 | - | - | Restricted Stock Unit | |
| Forestar Grp Inc - Ordinary Shares New | Lisa H. Jamieson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 2,000 | 2,000 | - | - | Restricted Stock Unit | |
| Forestar Grp Inc - Ordinary Shares New | Lisa H. Jamieson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 2,000 | 23,859 (0%) | 0% | 0 | Common Stock | |
| Forestar Grp Inc - Ordinary Shares New | Elizabeth Parmer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 2,000 | 2,000 (0%) | 0% | 0 | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.